New England Research & Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.18M Buy
2,801
+90
+3% +$70.1K 1.04% 27
2025
Q1
$2.24M Buy
2,711
+310
+13% +$256K 1.14% 24
2024
Q4
$1.85M Sell
2,401
-205
-8% -$158K 0.94% 31
2024
Q3
$2.31M Buy
2,606
+650
+33% +$576K 1.08% 27
2024
Q2
$1.77M Sell
1,956
-225
-10% -$204K 0.85% 41
2024
Q1
$1.7M Sell
2,181
-554
-20% -$431K 0.83% 38
2023
Q4
$1.59M Buy
2,735
+1,045
+62% +$609K 0.84% 40
2023
Q3
$908K Sell
1,690
-105
-6% -$56.4K 0.52% 71
2023
Q2
$842K Sell
1,795
-1,000
-36% -$469K 0.49% 72
2023
Q1
$960K Buy
2,795
+1,300
+87% +$447K 0.56% 65
2022
Q4
$547K Hold
1,495
0.31% 103
2022
Q3
$483K Buy
1,495
+210
+16% +$67.8K 0.3% 103
2022
Q2
$417K Sell
1,285
-149
-10% -$48.4K 0.24% 116
2022
Q1
$411K Buy
1,434
+124
+9% +$35.5K 0.21% 123
2021
Q4
$362K Hold
1,310
0.18% 133
2021
Q3
$303K Sell
1,310
-1,660
-56% -$384K 0.16% 147
2021
Q2
$682K Buy
2,970
+1,580
+114% +$363K 0.35% 96
2021
Q1
$260K Sell
1,390
-4,275
-75% -$800K 0.14% 151
2020
Q4
$956K Sell
5,665
-6,225
-52% -$1.05M 0.59% 60
2020
Q3
$1.76M Buy
+11,890
New +$1.76M 1.27% 20
2020
Q2
Sell
-8,390
Closed -$1.16M 154
2020
Q1
$1.16M Sell
8,390
-4,185
-33% -$581K 0.99% 30
2019
Q4
$1.65M Sell
12,575
-275
-2% -$36.1K 1.11% 23
2019
Q3
$1.44M Buy
12,850
+3,650
+40% +$408K 1.04% 23
2019
Q2
$1.02M Buy
+9,200
New +$1.02M 0.69% 48
2018
Q4
Sell
-2,650
Closed -$284K 173
2018
Q3
$284K Hold
2,650
0.18% 127
2018
Q2
$226K Sell
2,650
-1,400
-35% -$119K 0.15% 152
2018
Q1
$313K Buy
4,050
+1,200
+42% +$92.7K 0.21% 135
2017
Q4
$241K Sell
2,850
-1,450
-34% -$123K 0.17% 133
2017
Q3
$368K Hold
4,300
0.27% 103
2017
Q2
$354K Buy
+4,300
New +$354K 0.26% 113
2017
Q1
Sell
-5,440
Closed -$400K 177
2016
Q4
$400K Buy
+5,440
New +$400K 0.31% 108
2016
Q3
Sell
-7,400
Closed -$583K 176
2016
Q2
$583K Buy
+7,400
New +$583K 0.5% 64
2014
Q1
Sell
-12,075
Closed -$616K 149
2013
Q4
$616K Buy
+12,075
New +$616K 0.59% 65